{"created":"2023-05-15T14:51:52.375224+00:00","id":70910,"links":{},"metadata":{"_buckets":{"deposit":"6a6569e0-45b5-43e7-a972-eeb375177aab"},"_deposit":{"created_by":1,"id":"70910","owners":[1],"pid":{"revision_id":0,"type":"depid","value":"70910"},"status":"published"},"_oai":{"id":"oai:repo.qst.go.jp:00070910","sets":["10:28"]},"author_link":["696782","696789","696787","696788","696786","696783","696785","696784"],"item_10005_date_7":{"attribute_name":"発表年月日","attribute_value_mlt":[{"subitem_date_issued_datetime":"2012-09-21","subitem_date_issued_type":"Issued"}]},"item_10005_description_5":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"Metastasis control is one of the important issues in cancer treatment including radiation therapy (RT). Carbon-ion (C-ion)\nRT is an advanced RT using positively-charged carbon ion particles, and has achieved better results, especially local\ncontrol, due to the biological properties and excellent dose distribution. Previously, we reported that lung metastasis was\nnotably repressed by the combined therapy of C-ion irradiation and dendritic cell (DC) immunotherapy in a mouse\nmetastasis model using a squamous cell carcinoma cell line, NRS1, inoculated in a leg of C3H/He mice.\nIn this study, we aimed to obtain evidences for expanding the range of application for the combined therapy. We\nestablished mouse metastasis models using a lung cancer cell line, LLC, and an osteosarcoma cell line, LM8, inoculated\ninto C57BL/6J and C3H/He mice, respectively. Under conditions that there were no significant effects on growth of\ntransplanted tumor by the treatments, the number of lung metastasis was significantly decreased by only the combined\ntherapy, but not by C-ion irradiation or DC injection alone. This result clearly indicated that the combination therapy was\neffective for repressing metastasis.","subitem_description_type":"Abstract"}]},"item_10005_description_6":{"attribute_name":"会議概要（会議名, 開催地, 会期, 主催者等）","attribute_value_mlt":[{"subitem_description":"第71回日本癌学会学術総会","subitem_description_type":"Other"}]},"item_access_right":{"attribute_name":"アクセス権","attribute_value_mlt":[{"subitem_access_right":"metadata only access","subitem_access_right_uri":"http://purl.org/coar/access_right/c_14cb"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"下川, 卓志"}],"nameIdentifiers":[{"nameIdentifier":"696782","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"藤田, 英俊"}],"nameIdentifiers":[{"nameIdentifier":"696783","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"清野, 研一郎"}],"nameIdentifiers":[{"nameIdentifier":"696784","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"今井, 高志"}],"nameIdentifiers":[{"nameIdentifier":"696785","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"下川 卓志","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"696786","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"藤田 英俊","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"696787","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"清野 研一郎","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"696788","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"今井 高志","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"696789","nameIdentifierScheme":"WEKO"}]}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"conference object","resourceuri":"http://purl.org/coar/resource_type/c_c94f"}]},"item_title":"炭素線-樹状細胞併用療法による肺転移抑制の適応拡大を目指した基礎研究","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"炭素線-樹状細胞併用療法による肺転移抑制の適応拡大を目指した基礎研究"}]},"item_type_id":"10005","owner":"1","path":["28"],"pubdate":{"attribute_name":"公開日","attribute_value":"2012-09-25"},"publish_date":"2012-09-25","publish_status":"0","recid":"70910","relation_version_is_last":true,"title":["炭素線-樹状細胞併用療法による肺転移抑制の適応拡大を目指した基礎研究"],"weko_creator_id":"1","weko_shared_id":-1},"updated":"2023-05-15T19:57:24.706705+00:00"}